Belarus. Pharmaceutical companies - Borimed goes for IPO

One of these days Borisovskiy Zavod Medicinskikh Preparatov announced the firstnational public offering of corporate shares in Belarusian Stock Exchange, during which plans to raise up to 59.7 billion rubles. The so-called people's IPO scheduled forJune 29 to July 12. Shares in an amount of 125.5 thousand units at a price of 437 thousand rubles can buy a resident and foreign investors.

The estimated sale of shares is the additional issue. In full it will be 15% of the authorized fund of the company. In JSC "BZMP" the state has a 100% stake. But theproceeds from the sale of securities additional issue will arrive at the complete disposal of the enterprise. If selling government stake, the resources would go intostate coffers.

The main purpose is the sale of shares to raise funds for the implementation of investment projects on creation of tablet manufacturing with an investment of 164 billion rubles. At the moment, a new building came on the second floor.

Another objective of the company - to create a normal Joint Stock Company, whichwould not only be of public ownership, but private capital. "The first question is in talkswith strategic investors:" What percentage of the state?. "When people find out thatshe is with us 100%, they begin to express my skepticism," - says CEO. According to him, "we are currently negotiating with several very large strategists on equity." "These are two of the leading wholesaler company from Russia and from China," - he said.

State is ready to sell a controlling stake in JSC "Borisov Zavod Medicinskikh Preparatov" for 28-29 million dollars. "Authorized capital amounts to 221.4 billionrubles, plus additional issue now will be held on the amount of 59.7 billion As a result,the rate of National Bank, we find that the majority can do to a strategic investor in the28-29 million dollars", - he said. According to him, the recent devaluation of the ruble in this area has benefited. "The dollar has increased significantly and, if the market value before the plant was obviously too high and unrealistic, it is now down to a level thatcan hold a strategic investor. However, blocking still does remain in the state. More than 75% of authorities have not yet want to sell.

Net income in the year the plant is 10-12 million dollars. Around 60% of its production is exported. "The domestic market is of low profit, the prices of medical preparations are regulated by the state. For some positions BZMP even has a loss. But nothing, not evenin these circumstances exist well.

Borisov plant occupies nearly 40% of medicines in the kind produced in the country,and 20% of all medicines sold in Belarus.
Powered by Blogger.